Presented by ACC – Michigan and Foley & Lardner LLP
Thank you for attending our program entitled, “Forecasting Top Legal Issues Facing In-House Counsel in 2020.”
Agenda
- Navigating in Stormy Economic Seas: How to Protect and Maximize Your Interests in Dealing with Financially Distressed Companies
John Simon – Foley & Lardner LLP - Marijuana and the Workplace: Is Your Company Prepared
Felicia O’Connor – Foley & Lardner LLP - Panel Discussion: Legal Safeguards (and Potential Pitfalls) in Joint Development
Moderator: John Trentacosta – Foley & Lardner LLP
Panelists:- Nicholas Ellis – Foley & Lardner LLP
- Phil Phillips – Foley & Lardner LLP
- Marcus Sprow – Foley & Lardner LLP
- Forecasting and Navigating Tariffs and the Trade Wars
Vanessa Miller – Foley & Lardner LLP
Jenlain Scott – Foley & Lardner LLP - The Changing Landscape of Internal Investigations
Jennifer Belveal – Foley & Lardner LLP - Fireside Chat:Top Concerns Facing In-House Counsel and Strategies to Address Them
Moderator: Jennifer Neumann – Assistant General Counsel, American Axle & Manufacturing, Inc.
Panelists:- Andrew Bos – Associate General Counsel, RGIS
- Monica Navarro – Senior Counsel, Freudenberg North America
Program Materials
- Program Book
- Navigating in Stormy Economic Seas: How to Protect and Maximize Your Interests in Dealing with Financially Distressed Companies
- Marijuana and the Workplace: Is Your Company Prepared
- Forecasting and Navigating Tariffs and the Trade Wars
- The Changing Landscape of Internal Investigations
- Legal Safeguards Within Technology and Open Innovation – OESA Presentation
- Strategies for Protecting Against Vendor Payment Fraud
- Managing Supply Chain Risk – Best Practices to Avoid Liability for Your Supplier’s Freight Costs
- Financially Troubled Suppliers – Who Are They and How To Identify Them
Attorney Hosts
Related Insights
April 14, 2026
Health Care Law Today
FDA Clarifies Policies for Pharmacy Compounders of GLP-1 Products
On April 1, 2026,the U.S. Food & Drug Administration (FDA) issued a statement clarifying its compliance policy on the conditions that must be met for compounded drugs to qualify for the exemptions under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
April 14, 2026
Foley Career Perspectives
Trust Your Instincts: Susan Pravda on Leadership, Relationships, and Resilience
Foley partner Susan Pravda is a business lawyer focused on mergers and acquisitions, venture capital, initial public offerings, and related securities transactions and is head of Foley’s Health Care & Life Sciences Sector. She also serves as the firm’s chief strategic talent acquisition partner.
April 14, 2026
Blogs
When to Litigate and When to Walk Away
Clients faced with defending or initiating litigation often begin with the question: “Can we win?” The question sounds simple enough, and if the law is favorable, the instinctive answer might be “yes.” But “winning” in court doesn’t happen, and can’t be evaluated, in a vacuum. In reality, the odds of success in litigation depend not only on the law and facts of the case but also on any business constraints and potential consequences.